158 related articles for article (PubMed ID: 1692234)
1. The effect of smoking in pregnancy on maternal serum alpha-fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels.
Cuckle HS; Wald NJ; Densem JW; Royston P; Knight GJ; Haddow JE; Palomaki GE
Br J Obstet Gynaecol; 1990 Mar; 97(3):272-4. PubMed ID: 1692234
[No Abstract] [Full Text] [Related]
2. Adjustment formulae for maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol to maternal weight and smoking.
Bartels I; Hoppe-Sievert B; Bockel B; Herold S; Caesar J
Prenat Diagn; 1993 Feb; 13(2):123-30. PubMed ID: 7681977
[TBL] [Abstract][Full Text] [Related]
3. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
Extermann P; Bischof P; Marguerat P; Mermillod B
Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
[TBL] [Abstract][Full Text] [Related]
4. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
[TBL] [Abstract][Full Text] [Related]
5. Screening for Down syndrome at 14 weeks of pregnancy.
Wald NJ; Watt HC; Haddow JE; Knight GJ
Prenat Diagn; 1998 Mar; 18(3):291-3. PubMed ID: 9556047
[TBL] [Abstract][Full Text] [Related]
6. The effect of weight correction on risk calculations for Down's syndrome screening.
Reynolds TM; Penney MD; Hughes H; John R
Ann Clin Biochem; 1991 May; 28 ( Pt 3)():245-9. PubMed ID: 1714686
[TBL] [Abstract][Full Text] [Related]
7. Elevated maternal serum alpha-fetoprotein, very low unconjugated oestriol, and very low human chorionic gonadotropin associated with recent fetal death.
Walters CP; McKinnon WC
Prenat Diagn; 1993 May; 13(5):423-4. PubMed ID: 7688120
[No Abstract] [Full Text] [Related]
8. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
Burton BK; Prins GS; Verp MS
Am J Obstet Gynecol; 1993 Sep; 169(3):526-30. PubMed ID: 7690522
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome.
Wald NJ; Cuckle HS; Densem JW; Stone RB
Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176
[TBL] [Abstract][Full Text] [Related]
10. Second-trimester diurnal variation of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol: is it present and does it affect the prediction of a patient's risk for fetal Down syndrome?
Rose NC; Canick JA; Knight GJ; Pulkkinen A; Tumber MB; Mennuti MT; Palomaki GE
Prenat Diagn; 1994 Oct; 14(10):947-51. PubMed ID: 7534924
[TBL] [Abstract][Full Text] [Related]
11. Prenatal screening for Down's syndrome with use of maternal serum markers.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
[TBL] [Abstract][Full Text] [Related]
12. The role of maternal serum alpha-fetoprotein, human chorionic gonadotrophin and oestriol in the antenatal screening of Down's syndrome.
Chang TC; Cheng HH
Med J Malaysia; 1994 Dec; 49(4):351-4. PubMed ID: 7545778
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum screening for alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin between 11 and 15 weeks of pregnancy to detect fetal chromosome abnormalities.
Crandall BF; Hanson FW; Keener S; Matsumoto M; Miller W
Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1864-7; discussion 1867-9. PubMed ID: 7686337
[TBL] [Abstract][Full Text] [Related]
14. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
Liao S; Wang Y; Ye G
Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
[TBL] [Abstract][Full Text] [Related]
15. [Prenatal diagnosis of trisomy 21].
Massé J; Forest JC
Ann Biol Clin (Paris); 1990; 48(8):536-40. PubMed ID: 1705107
[TBL] [Abstract][Full Text] [Related]
16. Maternal serum screening.
Carroll JC
Can Fam Physician; 1994 Oct; 40():1756-64. PubMed ID: 7524838
[TBL] [Abstract][Full Text] [Related]
17. Biochemical screening tests for Down syndrome.
Coetzee E; Viljoen D
S Afr Med J; 1995 Feb; 85(2):72-3. PubMed ID: 7541163
[No Abstract] [Full Text] [Related]
18. Pregnancy hormone levels signal trisomy 21, improved screening, lower costs possible.
Randall T
JAMA; 1991 Apr; 265(14):1797-8. PubMed ID: 1706442
[No Abstract] [Full Text] [Related]
19. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.
Wald NJ; Cuckle HS; Densem JW; Kennard A; Smith D
Br J Obstet Gynaecol; 1992 Feb; 99(2):144-9. PubMed ID: 1372820
[TBL] [Abstract][Full Text] [Related]
20. Racial differences in maternal serum human chorionic gonadotropin and unconjugated oestriol levels.
Kulch P; Keener S; Matsumoto M; Crandall BF
Prenat Diagn; 1993 Mar; 13(3):191-5. PubMed ID: 7685088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
